Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title Sort ascending
    Grant Type
    Focus Area
    Country
    Application Due Date
    2025 Rheumatology Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Best Practices for Drug-Drug Interactions (DDIs) Management for Oral COVID-19 Antivirals
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    HER2+ Metastatic Breast Cancer (MBC) Care in Second-Line Treatment and Beyond
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
  • Title Sort ascending
    Grant Type
    Focus Area
    Country
    Application Due Date
    Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
    Release Date:
    Partner: Japanese Dermatological Association
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Vaccines for All: Longevity Unleashed for Everyone (VALUE)
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Japan
    UK Oncology Quality Improvement Grants
    Release Date:
    Review Process:
    Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
    Release Date:
    Review Process:
    Translating the Atopic Dermatitis (AD)
    Release Date:
    Review Process:
    Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
    Release Date:
    Review Process:
    Rheumatology Nurse Practitioner and Physician Assistant Fellowship
    Release Date:
    Review Process:
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Review Process:
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process: